Tag: stock market

GrowGeneration Corp.(GRWG:NSD) Wells Fargo lowers the target price to $3.50

Wells Fargo maintains GrowGeneration Corp. with an Equal-Weight rating and lowers the target price to $3.50 from $4 on the company’s stock.

Based on the GrowGeneration Corp stock forecasts from 6 analysts, the average analyst target price for GrowGeneration Corp is USD 10.80 over the next 12 months. GrowGeneration Corp’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of GrowGeneration Corp is Neutral, which is based on 7 positive signals and 7 negative signals. At the last closing, GrowGeneration Corp’s stock price was USD 3.90. GrowGeneration Corp’s stock price has changed by +1.30% over the past week, -22.92% over the past month and -90.52% over the last year.

GrowGeneration Corp., through its subsidiaries, owns and operates retail hydroponic and organic gardening stores in the United States. It engages in the marketing and distribution of nutrients, growing media, advanced indoor and greenhouse lighting, environmental control systems, vertical benching, and accessories for hydroponic gardening, as well as other indoor and outdoor growing products. The company serves commercial and urban cultivators growing specialty crops, including organics, greens, and plant-based medicines. As of March 01, 2022, it operated a chain of 63 stores, which includes 23 in California, 8 in Colorado, 7 in Michigan, 5 in Maine, 6 in Oklahoma, 4 in Oregon, 3 in Washington, 2 in Nevada, 1 in Arizona, 1 in Rhode Island, 1 in Florida, 1 in Massachusetts, and 1 in New Mexico, as well as growgeneration.com, an online superstore for cultivators. The company was formerly known as Easylife Corp. GrowGeneration Corp. was founded in 2008 and is based in Greenwood Village, Colorado.

What we like:

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What we don’t like:

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

 

ChargePoint Holdings Inc.(CHPT:NYE) Stifel Nicolaus Research lowers the target price to $26

Stifel Nicolaus Research maintains ChargePoint Holdings Inc with a Buy rating and lowers the target price to $26 from $32 on the company’s stock.

Based on the ChargePoint Holdings Inc stock forecasts from 11 analysts, the average analyst target price for ChargePoint Holdings Inc is USD 20.74 over the next 12 months. ChargePoint Holdings Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of ChargePoint Holdings Inc is Bearish, which is based on 1 positive signals and 4 negative signals. At the last closing, ChargePoint Holdings Inc’s stock price was USD 14.43. ChargePoint Holdings Inc’s stock price has changed by +15.35% over the past week, +30.94% over the past month and -55.75% over the last year.

ChargePoint Holdings, Inc. provides electric vehicle (EV) charging networks and charging solutions in the United States and internationally. It offers a portfolio of hardware, software, and services for commercial, fleet, and residential customers. The company was founded in 2007 and is headquartered in Campbell, California

What we like:

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What we don’t like:

Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

 

Blink Charging Co.(BLNK:NSD) Stifel Nicolaus Research cuts the target price to $19

Stifel Nicolaus Research maintains a Hold rating on Blink Charging Co. and cuts the target price to $19 from $30 on the company’s stock.

Based on the Blink Charging Co stock forecasts from 5 analysts, the average analyst target price for Blink Charging Co is USD 20.17 over the next 12 months. Blink Charging Co’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Blink Charging Co is Bearish, which is based on 1 positive signals and 4 negative signals. At the last closing, Blink Charging Co’s stock price was USD 16.38. Blink Charging Co’s stock price has changed by +8.98% over the past week, +9.35% over the past month and -57.75% over the last year.

Blink Charging Co., through its subsidiaries, owns, operates, and provides electric vehicle (EV) charging equipment and networked EV charging services in the United States and internationally. The company offers residential and commercial EV charging equipment that enable EV drivers to recharge at various location types. It also provides Blink Network, a cloud-based system that operates, maintains, and manages various Blink charging stations and associated charging data, back-end operations, and payment processing, as well as offers property owners, managers, parking companies, and state and municipal entities with cloud-based services that enable the remote monitoring and management of EV charging stations; and provides EV drivers with station information, including station location, availability, and applicable fees. In addition, the company provides EV charging hardware, software services, and service plans. It has strategic partnerships across transit/destination locations, including airports, auto dealers, healthcare/medicals, hotels, mixed-use, municipal locations, multifamily residential and condos, parks and recreation areas, parking lots, religious institutions, restaurants, retailers, schools and universities, stadiums, supermarkets, transportation hubs, and workplace locations. The company offers its services through direct sales force and resellers, as well as sells residential Level 2 chargers through various internet channels. As of March 10, 2022, it deployed approximately 30,000 charging ports. Blink Charging Co. was founded in 2009 and is headquartered in Miami Beach, Florida

What we like:

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

What we don’t like:

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector.

 

XBC:CA:TSX Xebec Adsorption Inc. – Stock Price, Quote and News

According to 9 analyst estimates for Xebec Adsorption Inc, the average analyst target price for Xebec Adsorption Inc. over the next 12 months is CAD 2.65. The average analyst recommendation for Xebec Adsorption Inc. is Buy. Xebec Adsorption Inc.’s stock analysis by Stock Target Advisor is Bearish, with 2 good signals and 7 negative signals. The stock price of Xebec Adsorption Inc. was CAD 0.90 at the latest close. The stock price of Xebec Adsorption Inc. has changed by -0.09% in the last week, -1.38 percent in the last month, and -81.85% in the last year.

In Canada, the United States, China, Korea, Italy, France, and other countries, Xebec Adsorption Inc. designs, manufactures and distributes purification, separation, dehydration, and filtration equipment for gases and compressed air. It operates in two segments: Systems and Support. Under the ADX Solutions brand, the company offers on-site air dehydration, BGX Solutions brand biogas for renewable natural gas systems, H2X Solutions brand hydrogen purification systems, NGX Solutions brand natural gas dehydration units for refuelling stations, and FSX Solutions brand products for air and gas filtration and separation. It also sells steam methane reforming products for making hydrogen from natural gas and electrolysis products for making hydrogen from electricity under the Hy.GEN-e brand, as well as on-site oxygen and nitrogen generators, industrial process chillers, fluid savers, pumping stations, compressed air and gas dryers and filters, spare parts and replacement filter elements, dew-point probes, and calibration services. Xebec Adsorption Inc. is based in Blainville, Canada, and was formed in 1967.

Xebec Adsorption Inc., a global provider of sustainable gas technology, released its first-quarter results for 2022, including the following highlights:

  • $41.2 million in revenue versus $20.6 million
  • The gross margin was $4.6 million (11%) versus $4.2 million (20 percent)
  • ($9.0) million adjusted EBITDA vs ($4.9) million
  • ($6.4) million adjusted EBITDA excluding legacy BGX activities compared to ($1.7) million.
  • The company lost $18.4 million, or $0.12 per share, compared to a loss of $10.1 million, or ($0.07) per share, in the previous quarter.
  • On May 11, 2022, the backlog was $260.5 million, compared to $88.5 million on May 12, 2021.
  • On March 31, 2022, working capital was $66.6 million, with a current ratio of 1.83:1, compared to $82.1 million and a current ratio of 1.96:1 on December 31, 2021.
  • On March 29, 2022, Xebec unveiled a three-year strategic plan to fuel the company’s expansion in sustainable gases, with a revenue target of $300–350 million and an adjusted EBITDA margin of 8%–10% for the fiscal year ending December 31, 2024.
  • Implementing the Center of Excellence Framework by the strategic strategy to ensure that the company expands sustainably by lowering its entire cost profile to meet long-term adjusted EBITDA targets
  • The company had $34.7 million in cash and restricted cash as of March 31, 2022, compared to $51.1 million as of December 31, 2021.
  • A non-IFRS measure is adjusted EBITDA. Stock-based compensation expenses, impairment of inventories, exchange gain/loss on the obligation arising from non-controlling interest participation in a subsidiary, foreign exchange loss (gain), accretion of debt, impairment charge of tangible assets, remeasurement of investments, M&A transaction fees, and one-time payments arising from the prior departure of employees and legal costs are all factored into Adjusted EBITDA.
  • Legacy BGX activities that are customized, Production-type RNG contracts are removed.
  • Revenues climbed by $20.6 million to $41.2 million in the three months ending March 31, 2022, compared to $20.6 million the previous year. Integration of newly acquired companies, delivery of second-generation Biostreams, and organic growth activities all contribute to the increase. Revenue from our Shanghai Joint Venture, which was fully consolidated last year, is partially offset by the rise.
  • When compared to the same period last year, gross margin increased from $4.2 million to $4.6 million for the three months ended March 31, 2022. Due to loss provisions taken for legacy RNG contracts presently in the beginning and commissioning process, lower margin hydrogen contracts, and rising material and supply chain expenses, the gross margin percentage has decreased from 20% to 11%.
  • Selling and administrative expenses (“SG&A”) were $16.2 million for the three months ended March 31, 2022, up to $5.5 million from $10.7 million for the same three months in 2021. Depreciation and amortization of intangible assets, as well as SG&A expenses related to recently acquired companies, accounted for $2.2 million of the rise.
  • For the three months ended March 31, 2022, the Company spent $0.7 million on research and development to continue developing its second-generation Bio stream product and novel hydrogen-generating technology.
  • For the three months ended March 31, 2022, other (gains) and losses totalled $3.7 million, compared to $1.7 million for the same three months in 2021. The rise is mostly attributable to a net loss on foreign currency exchange discrepancies, as well as a legal settlement and associated costs, which are partially offset by decreased integration and acquisition costs.
  • For the three months ended March 31, 2022, adjusted EBITDA loss excluding legacy BGX activities grew to $6.4 million from $1.7 million the previous year.
  • The operational deficit for the first three months of 2022 was $16.7 million, compared to $8.8 million in the same quarter of 2021. The increase in operating loss is mostly attributable to the lower gross margin mentioned above, as well as an increase in SG&A expenses as a result of acquisitions, as well as legal settlement and related costs.
  • In the three months ended March 31, 2022, the company lost $18.4 million, or $0.12 per share, compared to a loss of $10.1 million, or ($0.07) per share, in the same period the previous year.
  • For the three months ended March 31, 2022, adjusted EBITDA decreased to ($9.0) million from ($4.9) million the previous year.